Back to search results

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Abroad (travel likely)RecruitingPHASE1

Conditions

Graft Vs Host Disease · Graft-versus-host-disease · Graft Versus Host Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Ramzi Abboud, M.D.) · rabboud@wustl.edu · 314-454-8304
    Contact: Principal Investigator (Ramzi Abboud, M.D.)
    Camille Abboud, M.D. (Sub-investigator)
    Kelly Bolton, M.D. (Sub-investigator)
    Amanda Cashen, M.D. (Sub-investigator)
    Matt Christopher, M.D. (Sub-investigator)
    Zachary Crees, M.D. (Sub-investigator)
    John Dipersio, M.D., Ph.D. (Sub-investigator)
    Todd Fehniger, M.D., Ph.D. (Sub-investigator)
    Armin Ghobadi, M.D. (Sub-investigator)
    Meagan Jacoby, M.D., Ph.D. (Sub-investigator)
    Brad Kahl, M.D. (Sub-investigator)
    Iskra Pusic, M.D. (Sub-investigator)
    Mark Schroeder, M.D. (Sub-investigator)
    Keith Stockerl-Goldstein, M.D. (Sub-investigator)
    Geoffrey Uy, M.D. (Sub-investigator)
    Ravi Vij, M.D. (Sub-investigator)
    Matthew Walter, M.D. (Sub-investigator)
    Feng Gao, Ph.D. (Sub-investigator)
Study leads

  • Ramzi Abboud, M.D.

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)